Stealth BioTherapeutics Corp. (MITO) Stock Surging in Premarket, Here’s Why
Stealth BioTherapeutics Corp. (MITO), a clinical-stage biotechnology company, has surged 7.91% in the pre-market trading session. MITO stock is trading at $1.50 at the time of this writing. The rise seems to result from the presentation of positive SBT-272 preclinical data. On Thursday, MITO closed the day at $1.39 after increasing 1.46% during regular trading […]
Allogene Therapeutics, Inc. (ALLO) Stock Dipping in Aftermarket, Here’s Why
Allogene Therapeutics, Inc. (ALLO), a clinical-stage immuno-oncology company, has dipped 32.73% and hence, ALLO stock was trading at $16.40 when last checked. The reason for this massive decline seems to be the FDA clinical hold of AlloCAR T trials. On Thursday, ALLO stock closed the day at 24.338% after increasing 1.71%. FDA hold over AlloCAR […]
Vaxart, Inc. (VXRT) Stock Soaring in Aftermarket Trading Session, Here’s Why
Vaxart, Inc. (VXRT), a clinical-stage biotechnology company, has soared 10.72% in aftermarket trading session. Consequently, VXRT stock is changing hands at $7.85 at the time of writing. The increase has come after the positive study results about the impacts of Vaxart Covid vaccine candidate on Covid transmission. On Thursday, VXRT stock closed the day at […]
Sundial Growers Inc. (SNDL) Stock Surging in Aftermarket, Here’s Why
Sundial Growers Inc. (SNDL), a company engaged in the production and marketing of cannabis products, has surged 16.74% in aftermarket trading session and was trading at $0.76 when last checked. The reason for the increase could presumably be the acquisition of Alcanna Inc. by Sundial. On Thursday, SNDL stock closed the day at $0.65 after […]